Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 88.8% | 82.0% | 68.6% | 88.7% | 112.3% | 114.3% | 109.6% | 105.5% | 86.7% | 88.5% | 103.3% | 91.5% | 105.6% | 85.3% | 83.4% | 91.3% | 70.9% | 99.7% | 115.5% | 83.7% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 71.2%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Novo Nordisk A/S have been 92.7% over the past three years, and 98.1% over the past five years.
As of today, Novo Nordisk A/S's FCF to Net Income is 71.2%, which is lower than industry median of 83.9%. It indicates that Novo Nordisk A/S's FCF to Net Income is Bad.